Citadel Advisors
FHLTW

Citadel Advisors’s Future Health ESG Corp. Warrant FHLTW Stock Holding History

Citadel Advisors’s Portfolio FHLTW Stock Details FHLTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,953
Closed -$6.02K – 15795
2024
Q1 		$6.02K Sell
85,953
-356,614
-81% -$18K ﹤0.01% 13705
2023
Q4 		$9.96K Sell
442,567
-8,260
-2% -$231 ﹤0.01% 13127
2023
Q3 		$11.5K Sell
450,827
-100
-0% -$3 ﹤0.01% 13004
2023
Q2 		$9.02K Sell
450,927
-199
-0% -$8 ﹤0.01% 13281
2023
Q1 		$31.4K Sell
451,126
-176,690
-28% -$10.8K ﹤0.01% 12689
2022
Q4 		$39.6K Buy
627,816
+2,464
+0.4% +$167 ﹤0.01% 12432
2022
Q3 		$206K Buy
625,352
+11,479
+2% +$3.96K ﹤0.01% 10353
2022
Q2 		$178K Buy
613,873
+19,708
+3% +$5.63K ﹤0.01% 10822
2022
Q1 		$234K Sell
594,165
-10,971
-2% -$4.24K ﹤0.01% 11157
2021
Q4 		$297K Buy
+605,136
New +$302K ﹤0.01% 10957

Citadel Advisors's FHLTW Position: Q2 2024 in Review

Citadel Advisors sold out of Future Health ESG Corp. Warrant (FHLTW) in Q2 2024, closing a stake of 85,953 shares — an estimated $6.02K sold.

Citadel Advisors first reported a position in FHLTW in Q4 2021 and held it in 10 quarters. The position peaked at $297K in Q4 2021. 3 funds tracked by Wall St. Rank hold FHLTW as of Q2 2024.

  • Citadel Advisors reported no remaining Future Health ESG Corp. Warrant position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 85,953 Future Health ESG Corp. Warrant shares in Q2 2024, an estimated $6.02K.
  • Citadel Advisors first reported a position in Future Health ESG Corp. Warrant in Q4 2021 and held it in 10 quarters.
  • Citadel Advisors's Future Health ESG Corp. Warrant position peaked at $297K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Future Health ESG Corp. Warrant as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.